» Articles » PMID: 15056602

Diet, Diabetes and Schizophrenia: Review and Hypothesis

Overview
Specialty Psychiatry
Date 2004 Apr 2
PMID 15056602
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes is more common in people with schizophrenia than in the general population.

Aims: To explore the possible reasons for the association between diabetes and schizophrenia.

Method: Diet and other lifestyle factors in patients with schizophrenia were reviewed as risk factors for diabetes.

Results: People with schizophrenia show features of the metabolic syndrome at the onset of illness, before treatment. They also eat a poor diet, take little exercise and have high rates of smoking. Food intake may be increased further by antipsychotic medication. Nutritional factors appear to have a key role in the development of diabetes in patients with schizophrenia and may also affect the outcome and severity of schizophrenia. A common pathway through which diet might contribute to the development of both diabetes and schizophrenia is proposed.

Conclusions: Lifestyle factors may influence outcomes in both diabetes and schizophrenia. Lifestyle interventions are the key to improving the long-term health of people with schizophrenia.

Citing Articles

A Cross-Sectional Comparative Study: Could Asprosin and Peptide Tyrosine-Tyrosine Be Used in Schizophrenia to Define the Disease and Determine Its Phases?.

Tozoglu E, Gurbuzer N, Ozkaya A, Akyildirim S Diagnostics (Basel). 2025; 15(5).

PMID: 40075879 PMC: 11899270. DOI: 10.3390/diagnostics15050632.


Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review).

Manta A, Georganta A, Roumpou A, Zoumpourlis V, Spandidos D, Rizos E Mol Med Rep. 2025; 31(5).

PMID: 40017113 PMC: 11894597. DOI: 10.3892/mmr.2025.13479.


Relevance of diet in schizophrenia: a review focusing on prenatal nutritional deficiency, obesity, oxidative stress and inflammation.

Rarinca V, Vasile A, Visternicu M, Burlui V, Halitchi G, Ciobica A Front Nutr. 2024; 11:1497569.

PMID: 39734678 PMC: 11673491. DOI: 10.3389/fnut.2024.1497569.


Investigating the Impacts of Diet, Supplementation, Microbiota, Gut-Brain Axis on Schizophrenia: A Narrative Review.

Zajkowska I, Niczyporuk P, Urbaniak A, Tomaszek N, Modzelewski S, Waszkiewicz N Nutrients. 2024; 16(14).

PMID: 39064675 PMC: 11279812. DOI: 10.3390/nu16142228.


Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome.

DeJongh B Ment Health Clin. 2021; 11(6):311-319.

PMID: 34824956 PMC: 8582768. DOI: 10.9740/mhc.2021.11.311.